NEW ISOFORMS OF VASCULAR ENDOTHELIAL CELL GROWTH INHIBITOR Russian patent published in 2008 - IPC C12N15/12 C12N15/62 C12N15/63 C07K19/00 C07K16/18 A61K38/17 A61P35/00 A61P43/00 

Abstract RU 2316591 C2

FIELD: biotechnology, molecular biology.

SUBSTANCE: invention proposes a polynucleotide VEGI-192a encoding polypeptide that inhibits growth of human vascular endothelial cells. Invention describes expressing vector comprising polynucleotide and E. coli cell-host comprising vector. Invention discloses polypeptide encoded by polynucleotide and fused protein based on indicated polypeptide. Invention describes polynucleotide encoding fused protein and expressing vector based on indicated polynucleotide. Invention discloses a pharmaceutical composition used for inhibition of angiogenesis based on polypeptide-inhibitor of growth of human vascular endothelial cells and polynucleotide encoding its. Invention describes therapeutic methods for inhibition of angiogenesis and suppression of tumor growth based on this composition. Invention describes an antibody raised to polypeptide that inhibits growth of human vascular endothelial cells. Using this invention provides novel forms of inhibitor of human growth of vascular endothelial cells and can be used in medicine.

EFFECT: valuable biological and medicinal properties of inhibitor.

27 cl, 27 dwg, 13 tbl, 34 ex

Similar patents RU2316591C2

Title Year Author Number
BIOMARKERS BASED ON TUMOR TISSUE FOR COMBINED THERAPY WITH BEVACIZUMAB 2011
  • Delmar Pol
  • Ferntsler Dorote
  • Sherer Stefan
RU2605282C2
WNT ANTAGONISTS AND METHODS OF TREATING AND TESTING 2011
  • Satyal Sandzhiv Kh.
  • Mitra Satyadzhit Sudzhit Kumar
  • Garni Ostin L.
RU2593947C2
NON-NATURAL CLASS 3 SEMAPHORINS AND THEIR MEDICAL APPLICATION 2016
  • Serini Gvido
  • Dzhiraudo Enriko
  • Tamanone Luka
RU2722832C2
ANTI-CANCER VACCINES TARGETED WITH SURVIVIN AND THEIR APPLICATION 2018
  • Yan, Jian
  • Slager, Anna
  • Garman, Bradley
  • Cooch, Neil
RU2751253C1
SURVIVIN-TARGETED ANTI-CANCER VACCINES AND APPLICATIONS THEREOF 2018
  • Yan, Jian
  • Slager, Anna
  • Garman, Bradley
  • Cooch, Neil
RU2776949C2
THERAPEUTIC USE OF VEGF-C AND CCBE1 2014
  • Alitalo Kari
  • Eltsh Mikhael
  • Anisimov Andrej
RU2691104C2
NEW MODULATORS AND METHODS OF THEIR APPLICATION 2012
  • Foord Orit
  • Dylla Scott J.
  • Stull Robert A.
  • Bankovich Alex
  • Lazetic Alexandra Leida Liana
  • Bernstein Jeffrey
RU2627176C2
ACTIVIN-ActRIIa-Fc ANTAGONISTS AND USE THEREOF FOR TREATING OR PREVENTING BREAST CANCER 2008
  • Nopf Dzhon
  • Sikhra Dzhasbir
  • Kumar Ravindra
RU2473362C2
ANTIBODIES TO FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND APPLICATION 2011
  • Eb Olga
  • Tavares Deniel
  • Rui Linyun
  • Pejn Dzhillian
  • Goldmakher Viktor S.
RU2610663C2
VERSIONS OF DISINTEGRIN AND THEIR PHARMACEUTICAL APPLICATION 2015
  • Chuan Voej-Tsze
RU2685869C1

RU 2 316 591 C2

Authors

Li Lujuan

Pan Khongguang

Dates

2008-02-10Published

2002-11-12Filed